Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 16, 2004
Event: Announcement of financial results for the third quarter and nine months ended September 30, 2004.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific comparative data or details regarding material changes versus prior periods. It only confirms the issuance of results for the period ended September 30, 2004.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information in the report is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures.
- Verify the specific details of the third quarter and nine-month performance not included in this summary text.
- Check for any forward-looking statements or risk disclosures contained within the referenced press release.